AIFM2 and gastric cancer: In gastric cancer cells, the proteins glycerol-3-phosphate dehydrogenase 1 (GPD1) and glycerol-3-phosphate dehydrogenase 1-like (GPD1L) drive aberrant lipid droplet accumulation, which subsequently elevates FSP1 expression, enhances resistance to ferroptosis, and promotes peritoneal metastasis [40].